Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 27, 2024
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J Murphy, Suresh Muthukumaraswamy, Harriet de Wit
BMC Neuroscience
|
February 5, 2024
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J Murphy, Kate Godfrey, Alexander D Shaw, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 19, 2025
Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers
James D Morse, Soo Hee Jeong, Robin J Murphy, et al.
Psychopharmacology
|
September 5, 2024
Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
Robin J Murphy, Rachael L Sumner, Kate Godfrey, et al.
Trials
|
May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Trials
|
April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Biological Psychiatry
|
March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J Murphy, Rachael Sumner, William Evans, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Trials
|
August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 27, 2024
Microdosing Psychedelics: Current Evidence From Controlled Studies
Robin J Murphy, Suresh Muthukumaraswamy, Harriet de Wit
BMC Neuroscience
|
February 5, 2024
Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
Robin J Murphy, Kate Godfrey, Alexander D Shaw, et al.
Journal of Psychopharmacology (Oxford, England)
|
April 19, 2025
Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers
James D Morse, Soo Hee Jeong, Robin J Murphy, et al.
Psychopharmacology
|
September 5, 2024
Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
Robin J Murphy, Rachael L Sumner, Kate Godfrey, et al.
Trials
|
May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Trials
|
April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers
Robin J Murphy, Rachael L Sumner, William Evans, et al.
Biological Psychiatry
|
March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial
Robin J Murphy, Rachael Sumner, William Evans, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2026
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a phase 2a trial
Dimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Trials
|
August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
Dimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.
Page
of 1